Correlation Between Innovation1 Biotech and Health Sciences
Can any of the company-specific risk be diversified away by investing in both Innovation1 Biotech and Health Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovation1 Biotech and Health Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovation1 Biotech and Health Sciences Gr, you can compare the effects of market volatilities on Innovation1 Biotech and Health Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovation1 Biotech with a short position of Health Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovation1 Biotech and Health Sciences.
Diversification Opportunities for Innovation1 Biotech and Health Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Innovation1 and Health is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Innovation1 Biotech and Health Sciences Gr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Sciences Gr and Innovation1 Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovation1 Biotech are associated (or correlated) with Health Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Sciences Gr has no effect on the direction of Innovation1 Biotech i.e., Innovation1 Biotech and Health Sciences go up and down completely randomly.
Pair Corralation between Innovation1 Biotech and Health Sciences
Given the investment horizon of 90 days Innovation1 Biotech is expected to generate 10.23 times more return on investment than Health Sciences. However, Innovation1 Biotech is 10.23 times more volatile than Health Sciences Gr. It trades about 0.04 of its potential returns per unit of risk. Health Sciences Gr is currently generating about -0.06 per unit of risk. If you would invest 45.00 in Innovation1 Biotech on August 25, 2024 and sell it today you would lose (44.90) from holding Innovation1 Biotech or give up 99.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.66% |
| Values | Daily Returns |
Innovation1 Biotech vs. Health Sciences Gr
Performance |
| Timeline |
| Innovation1 Biotech |
| Health Sciences Gr |
Innovation1 Biotech and Health Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Innovation1 Biotech and Health Sciences
The main advantage of trading using opposite Innovation1 Biotech and Health Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovation1 Biotech position performs unexpectedly, Health Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Sciences will offset losses from the drop in Health Sciences' long position.The idea behind Innovation1 Biotech and Health Sciences Gr pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Health Sciences vs. Embotelladora Andina SA | Health Sciences vs. Signet International Holdings | Health Sciences vs. National Beverage Corp | Health Sciences vs. PT Astra International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |